FI  Knoll Capital Management




     Office Locations:

5 East 44th St, Suite 12
New York, NY 10017

 

Stages:

  • Growth
  • Middle Market


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    Knoll Capital Management is an investment management firm founded by Fred Knoll. Knoll runs the trust for the benefit of his family and it was the fifth-biggest owner of cancer drug maker Medivation's shares at the end of 2015. His 2.67% stake in Medivation made up 79% of Knoll's $270 million U.S. stock portfolio at the end of 2015, Securities & Exchange Commission filings show. Knoll's stake in Medivation alone is now worth $270 million. Knoll has led Knoll Capital Management since 1987, and he personally manages Knoll Capital Fund I and Knoll Capital Fund II. The firm's current investments mostly consist of biotech companies.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Fred Knoll Principal, President & Portfolio Manager
    Patrick George O'Neill COO

     

    Portfolio companies include:


      Abeona Therapeutics


      Aldeyra Therapeutics


      Ampio Pharmaceuticals


      Anavex Life Sciences


      Biohaven Pharmaceuticals


      Corbus Pharmaceuticals


      Krystal Biotech


      Soligenix
        web link


      Vascular Biogenics
        web link


      Volition


     

    Recent News: